You will have received correspondence from the Pharmaceutical Society of Northern Ireland in respect of the launch of the Customer Relationship Management system, Regulator Online (ROL) which is used to complete registration activities (such as updating personal details, completing annual retention and submitting applications).
Additionally, in respect of Continuous Professional Development (CPD), pharmacists can use the portal to:
record CPD cycles throughout the CPD year;
submit, amend and re-submit annual CPD portfolios;
apply for Extenuating Circumstances; and
retain all CPD records.
The CPD section of ROL is now active.
ACTION
Contractors are advised to:
Note the correspondence from The Pharmaceutical Society NI.
Visit portal.psni.org.uk and log in with your Membership online (members.psni.org.uk) username and password noting that the two systems are currently separate. If you reset your password on one system, it will not reset on both.
Note that if you need further guidance on logging in on the new CPD portal, please visit the PSNI website for a 1 minute tutorial video.
Any queries should, in the first instance, be directed to the Pharmaceutical Society of Northern Ireland.
Kind regards – Mike
SENT ON BEHALF OF PROF. MIKE MAWHINNEY Head of Regulatory Affairs
Dear Colleague
The fifth update concessionary prices were granted for January 2022:
Drug
Pack Size
Concessionary Price
Brinzolamide 10mg/ml / Timolol 5mg/ml eye drops
5
£4.52
Celecoxib 200mg capsules
30
£6.20
Clonidine 25microgram tablets
112
£8.24
Co-amilozide 5mg/50mg tablets
28
£15.48
Dexamethasone 2mg tablets
50
£3.81
Dipyridamole 100mg tablets
84
£6.95
Famotidine 40mg tablets
28
£26.41
Isotretinoin 20mg capsules
30
£14.02
Ivabradine 2.5mg tablets
56
£25.21
Lisinopril 5mg tablets
28
£0.80
Losartan 100mg / Hydrochlorothiazide 25mg tablets
28
£11.21
Methocarbamol 750mg tablets
100
£12.73
Midazolam 10mg/2ml solution for injection ampoules
10
£5.73
Naftidrofuryl 100mg capsules
84
£6.79
Oxybutynin 5mg tablets
56
£1.45
Pravastatin 40mg tablets
28
£1.59
Rivastigmine 3mg capsules
28
£3.31
Ropinirole 500microgram tablets
28
£5.22
Sulfasalazine 500mg gastro-resistant tablets
112
£27.70
Sulfasalazine 500mg tablets
112
£24.28
Tacrolimus 0.1% ointment
60
£36.99
Timolol 0.5% eye drops
5
£2.60
Tolterodine 2mg tablets
56
£2.97
Trazodone 100mg capsules
56
£3.45
Rivastigmine 1.5mg capsules
28
£3.66
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter. Concessionary prices are also published on the CPNI website.
Kind regards
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
Dear Colleague
As you know, CPNI has been issuing updates relating to the EU Falsified Medicines Directive (FMD) which imposes legal obligations aimed at helping to prevent entry of falsified medicinal products into the supply chain. The Delegated Regulation was implemented in all EU Member States on 9 February 2019 and is still a legal requirement in Northern Ireland.
We wrote to you recently HEREadvising that SecurMed will be implementing a new version of the UKNI Medicines Verification System (UKNI MVS) in April 2022 and advising you to contact your IT provider to ensure that you have the correct version installed.
We have been in touch with McLernons, one of the pharmacy IT providers, and they have confirmed that there is no need for individual contractors to contact their Service Desk, as the required software changes will be in place before the new version of the UKNI MVS is released in April 2022.
ACTION
Contractors are advised to:
Note the advice in respect of McLernons.
Kind regards – Mike
SENT ON BEHALF OF PROF. MIKE MAWHINNEY Head of Regulatory Affairs
Dear Colleague
You will have received a letter from Joe Brogan, Assistant Director of Integrated Care, Head of Pharmacy and Medicines Management reminding contractors that the use of the private controlled drug requisition form (CDRF1) is mandated in the circumstances outlined (see the letter HERE for full details).
Contractors are required to ensure that:
Schedule 2 or 3 CD stocks for private or non-Health Service purposes are only supplied via a CDRF1 form
The CDRF1 is signed by an authorised person
The person/organisation ordering the CDs fully completes part two of the CDRF1 form – see guidance notes on the reverse of the CDRF1 form
The pharmacist supplying the CDs fully completes part three of the CDRF1 form – see guidance notes on the reverse of the CDRF1 form
Original completed CDRF1 forms (not copies) are submitted to the Business Services Organisation (BSO) ideally at the end of the month in which they are received, with the exemption of veterinary requisitions and those relating to inter-pharmacy stock transfers; these are not required to be submitted to BSO.
It is recommended that a copy of the CDRF1 form is retained in the pharmacy
ACTION
Contractors should ensure that:
Staff involved in the management and use of CDs are fully apprised of the content of this letter; and
SOPs reflect the legal requirements as appropriate.
Kind regards – Mike
SENT ON BEHALF OF PROF. MIKE MAWHINNEY Head of Regulatory Affairs
Dear Colleague
As you know, CPNI has been issuing updates relating to the EU Falsified Medicines Directive (FMD) which imposes legal obligations aimed at helping to prevent entry of falsified medicinal products into the supply chain. The Delegated Regulation was implemented in all EU Member States on 9 February 2019 and is still a legal requirement in Northern Ireland.
SecurMed has written to you recently advising that they will be implementing a new version of the UKNI Medicines Verification System (UKNI MVS) in April 2022.
This requires a change in the software and scanner system you use to connect to it. SecurMed indicates that your software supplier has been informed of this and should have implemented (or be preparing to implement) the relevant changes to update their End User software for continuation of your access to the UKNI MVS.
If your software and scanner system is not up to date when the new system is rolled out, you will no longer be able to access the UKNI MVS and you will not be able to remain compliant with FMD requirements.
ACTION
Contractors are advised to:
Check with your software supplier to ensure that you have the updated version of your FMD software installed (or will have it installed by April 2022). You should ask your software supplier to confirm that your NMVS software is, or will be, compatible with NMVS Core 1.10.
If you have any queries, please raise them with your software supplier in the first instance.
Kind regards – Mike
SENT ON BEHALF OF PROF. MIKE MAWHINNEY Head of Regulatory Affairs
Dear Colleague
Please find correspondence HERE from HSCB Pharmacy and Medicines Management.
SUMMARY
HSCB have been made aware of fraudulent private prescriptions having been presented in the Belfast area.
A female presented a prescription for diazepam reportedly from a GP surgery in Dublin. The address of the ‘patient’ was in Clondalkin, Co. Dublin. The pharmacist contacted the practice concerned who advised this was a false prescription. At this time the female left the pharmacy and the prescription was not dispensed.
On the same day an individual presented a prescription for Diazepam and Stemetil in a separate area of Belfast. The GP was a genuine GP in Tallaght Cross, Dublin. As far as the pharmacist knows, all the details on the script were accurate (telephone number, registration etc.) but it was a forged script. This prescription was dispensed.
Pharmacists are reminded that when supplying medications and in particular medicines liable to abuse/misuse, against any prescription, due diligence must be taken to satisfy themselves that the prescription is genuine.
Please report all confirmed instances of false prescriptions, whether medication was obtained or not, firstly to the PSNI on 101 (or 999 in the case of an emergency) and also to BSO Counter Fraud and Probity Services (see HERE).
Please do not hesitate to contact your local Local Integrated Care Offices or the CPNI office should you require any further information.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.